Australia markets closed

Cochlear Limited (COH.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
216.88+1.48 (+0.69%)
At close: 4:10PM AEDT

Cochlear Limited

1 University Avenue
Macquarie University
Sydney, NSW 2109
Australia
61 2 9428 6555
http://www.cochlear.com

Sector(s):Β Healthcare
Industry:Β Medical Devices
Full-time employees:Β 4,000

Key executives

NameTitlePayExercisedYear born
Mr. Diggory William Howitt BE (Hons), MBACEO, MD, Pres & Exec. Director4.05MN/A1967
Mr. Stuart SayersChief Financial Officer692.93kN/AN/A
Mr. Jan JanssenChief Technology Officer1.68MN/A1965
Mr. Richard Brook MBAPres of EMEA1.69MN/AN/A
Mr. Anthony MannaPres of Americas Region1.62MN/AN/A
Mr. Anthony BishopPres of Asia Pacific & Latin American Regions1.09MN/AN/A
Mr. David HackshallChief Information OfficerN/AN/AN/A
Ms. Kristina DevonVP of Investor RelationsN/AN/AN/A
Ms. Jennifer StevensonVP of Corp. CommunicationsN/AN/AN/A
Mr. Dean PhizackleaSr. VP of Global Strategic MarketingN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Cochlear Limited provides implantable hearing solutions for adults and children worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.

Corporate governance

Cochlear Limited’s ISS governance QualityScore as of 26 September 2021 is 3. The pillar scores are Audit: 5; Board: 4; Shareholder rights: 7; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.